Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert D'Haens

Showing results (51-60 of 269) with videos related to

Pageof 27
Sort By:
Inflammatory Bowel Diseases|June 1, 2004
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitisJoris Arts, Geert D'Haens, Miranda Zeegers, et al.
Journal of Crohn'S & Colitis|April 27, 2018
Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE TrialsRemo Panaccione, William J Sandborn, Geert D'Haens, et al.
United European Gastroenterology Journal|June 12, 2014
Comparison of six different calprotectin assays for the assessment of inflammatory bowel diseaseDelphine Labaere, Annick Smismans, August Van Olmen, et al.
Inflammatory Bowel Diseases|March 30, 2021
Natural History and Risk Stratification of Recurrent Crohn's Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort StudyVincent Joustra, Marjolijn Duijvestein, Aart Mookhoek, et al.
Journal of Crohn'S & Colitis|September 30, 2017
The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?Pieter Hindryckx, Niels Vande Casteele, Gregor Novak, et al.
Journal of Crohn'S & Colitis|April 28, 2012
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patientsFilip Baert, Elien Glorieus, Cathérine Reenaers, et al.
Gastrointestinal Endoscopy|August 4, 2015
Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trialPaul Rutgeerts, Walter Reinisch, Jean-Frederic Colombel, et al.
Acta Gastro-Enterologica Belgica|March 26, 2009
Cytomegalovirus colitis in an apparently immunecompetent host after biliopancreatic diversion for obesityStijn Van Gool, Lieve Van Casteren, Otto Buchel, et al.
Gut|October 5, 2014
A phase II study of laquinimod in Crohn's diseaseGeert D'Haens, William J Sandborn, Jean Frederic Colombel, et al.
Gastroenterology|October 1, 2003
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitisGert Van Assche, Geert D'Haens, Maja Noman, et al.
Pageof 27

Showing results (51-60 of 269) with videos related to

Sort By:
Pageof 27
Inflammatory Bowel Diseases|June 1, 2004
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitisJoris Arts, Geert D'Haens, Miranda Zeegers, et al.
Journal of Crohn'S & Colitis|April 27, 2018
Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE TrialsRemo Panaccione, William J Sandborn, Geert D'Haens, et al.
United European Gastroenterology Journal|June 12, 2014
Comparison of six different calprotectin assays for the assessment of inflammatory bowel diseaseDelphine Labaere, Annick Smismans, August Van Olmen, et al.
Inflammatory Bowel Diseases|March 30, 2021
Natural History and Risk Stratification of Recurrent Crohn's Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort StudyVincent Joustra, Marjolijn Duijvestein, Aart Mookhoek, et al.
Journal of Crohn'S & Colitis|September 30, 2017
The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?Pieter Hindryckx, Niels Vande Casteele, Gregor Novak, et al.
Journal of Crohn'S & Colitis|April 28, 2012
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patientsFilip Baert, Elien Glorieus, Cathérine Reenaers, et al.
Gastrointestinal Endoscopy|August 4, 2015
Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trialPaul Rutgeerts, Walter Reinisch, Jean-Frederic Colombel, et al.
Acta Gastro-Enterologica Belgica|March 26, 2009
Cytomegalovirus colitis in an apparently immunecompetent host after biliopancreatic diversion for obesityStijn Van Gool, Lieve Van Casteren, Otto Buchel, et al.
Gut|October 5, 2014
A phase II study of laquinimod in Crohn's diseaseGeert D'Haens, William J Sandborn, Jean Frederic Colombel, et al.
Gastroenterology|October 1, 2003
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitisGert Van Assche, Geert D'Haens, Maja Noman, et al.
Pageof 27